

Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330...
You can purchase shares of Addex Therapeutics (NASDAQ:ADXN) through any online brokerage.
Other companies in Addex Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Addex Therapeutics has a consensus price target of $30.00.
The stock price for Addex Therapeutics (NASDAQ: ADXN) is $2.99 last updated October 23, 2026 at 9:18 AM EDT.
There are no upcoming dividends for Addex Therapeutics.
Addex Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Addex Therapeutics.
Addex Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's...